Medical male circumcision for HIV has benefits for women too

Carlos Toledo presenting at IAS 2017. Photo by Roger Pebody,
Roger Pebody
Published: 26 July 2017

South African women whose most recent sexual partner was circumcised are less likely to have HIV, suggesting that the voluntary medical male circumcision programmes have benefits for women too, according to a study presented to the 9th International AIDS Society Conference on HIV Science (IAS 2017) in Paris yesterday.

It is well established that circumcision protects men against HIV infection, but until now there has been little evidence of benefit for women. Almost a decade ago, a meta-analysis found no evidence to suggest that circumcision directly reduced the risk of women acquiring HIV.

Studies have shown a reduced risk of human papillomavirus, genital ulcers, herpes simplex virus type 2, syphilis, bacterial vaginosis, and T vaginalis in women whose partners are circumcised. This is likely due to changes in the male partner’s anatomy, making transmission of an infection less likely.

However, in the case of HIV, it is more likely that male circumcision can benefit women by reducing the prevalence of HIV in men who have been circumcised.

Carlos Toledo and colleagues from the Centers for Disease Control and Prevention analysed data from the HIV Incidence Provincial Surveillance System, a longitudinal cohort drawn from a representative sample of households in two sub-districts of KwaZulu Natal, South Africa. There is an extremely high prevalence of HIV and other sexually transmitted infections (STIs) in KwaZulu Natal.

Among 3540 male participants in the survey, the proportions who had been medically circumcised were higher among the younger men, reflecting the recent introduction of the procedure. For example, 51% of men aged 15 to 19 were circumcised, 45% of men aged 20 to 24 and 28% of men aged 25 to 29, while in all age groups over 35, fewer than 20% were circumcised. KwaZulu Natal is predominantly Zulu and circumcision does not play an important role in Zulu customs; only 10% of men had had a traditional (rather than a medical) circumcision.

As could be expected, circumcised men were less likely to have HIV and other STIs. This could be due to both the protective effect of circumcision and the younger age of circumcised men.

The main analysis concerned 4766 female members of the cohort, aged 15 to 49, who provided information on the circumcision status of their most recent sexual partner. Participants were tested for HIV and a series of STIs, as well as being asked about STI symptoms and diagnoses.

There were a number of differences between the 35% of women whose partner was circumcised and the 65% of women whose partner was not. Women with circumcised partners were younger and had lower incomes, larger households, more education, fewer pregnancies and slightly fewer total partners.

Women whose most recent partner was circumcised also had lower rates of HIV (42%) than women whose partner was not circumcised (54%).

In a multivariable analysis, which attempted to control for the skewing effect of the other differences between the two groups of women, women with circumcised partners had a 30% lower likelihood of having HIV (adjusted odds ratio 0.71, 95% confidence interval 0.59-0.86). They were also less likely to have herpes simplex virus type 2 (adjusted odds ratio 0.78, 95% confidence interval 0.66-0.92).

Carlos Toledo acknowledged some limitations with these cross-sectional data – some of the women may have said that their partner was circumcised when in fact he had had a ‘traditional’ circumcision that did not involve the complete removal of the foreskin. Such a circumcision would provide much less protection than a medical circumcision. The analysis only took into account the circumcision status of the woman’s most recent partner, whereas she has probably had other partners too. Future analyses will attempt to more fully capture this history. Finally, when a man accesses voluntary male medical circumcision services, he receives a package of services including screening and treatment for STIs and HIV. The reduced prevalence of infections in women could be partly due to these interventions.

But Toledo said that the findings support the idea that male circumcision provides some community-level protection against HIV. The impact of the scale up of male circumcision has implications for women’s health and there could be synergies between circumcision and women’s health programmes, he said.


Toledo C et al. Association between HIV and sexually transmitted infections and partner circumcision among women in uMgungundlovu District, South Africa: a cross-sectional analysis of HIPSS baseline data. 9th IAS Conference on HIV Science, Paris, abstract TUAC0404, July 2017.

View the abstract on the conference website.

Download the presentation slides from the conference website.

Watch the webcast of this session on YouTube.


South Africa

Find details of HIV services in South Africa, the latest news from the country, and a selection of resources from local organisations.

Find out more about South Africa >

NAM's news coverage of the International AIDS Society's Conference on HIV Science has been made possible thanks to support from Gilead Sciences Europe Ltd. and Merck & Co. NAM's wider conference news reporting services have been supported by Janssen and ViiV Healthcare.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.